Document is current
Any future updates will be listed below
-
Authors
Capovilla, Giovanni
Pierobon, Elisa Sefora
Moletta, Lucia
Scarton, Alessia
Sciuto, Maria Elisa
Tagkalos, Evangelos
Uzun, Eren
De Pasqual, Carlo Alberto
Turolo, Cecilia
Zanchettin, Gianpietro
Riccio, Federica
Provenzano, Luca
Salvador, Renato
Berlth, Felix
Weindelmayer, Jacopo
Lonardi, Sara
Galuppo, Sara
Giacopuzzi, Simone
De Manzoni, Giovanni
Grimminger, Peter
Valmasoni, Michele
-
Funding
Funding for this research was provided by:
Università degli Studi di Padova
- License Information
-
More Information
Article History
Received: 12 November 2024
Accepted: 16 March 2025
First Online: 5 May 2025
Disclosure
: Sara Lonardi: Research funding (to Institution) from Amgen, Astellas, Astra Zeneca, Bayer, Bristol-Myers Squibb, Daichii Sankyo, Hutchinson, Incyte, Merck Serono, Mirati, MSD, Pfizer, Roche, Servier, personal honoraria as invited speaker from Amgen, Astra Zeneca, Bristol-Myers Squibb, Incyte, GSK, Lilly, Merck Serono, MSD, Pierre-Fabre, Roche, Servier; Participation in advisory board for Amgen, Astellas, Astra Zeneca, Bayer, Bristol-Myers Squibb, Daiichi-Sankyo, GSK, Incyte, Lilly, Merck Serono, MSD, Servier, Takeda, Rottapharm, Beigene, Fosum, Nimbus Therapeutics. Peter Grimminger: Proctor for Intuitive Surgical, Advisor for Medicaroid Europe, Medtronic, Richard Wolf and JnJ.
